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ABSTRACT Objective: This article presents the healthy pattern of eye movements (EM) in 145 healthy
volunteers from 20 to 86 years old. Volunteers were classified into four groups according to their age.
A saccadic paradigm, in horizontal and vertical axes, was performed. We described a pattern behavior in
healthy volunteers to demonstrate that it can be used to measure the aging and functionality of the brain.
Methods: A gaze-tracker based in video-oculography technology was used. Before EM tests, clinical data
were collected, participants performed a cognitive test to discard subtle abnormalities and signed an informed
consent form. To demonstrate the relationship between EM and brain aging, a linear or quadratic model
was computed and statistical analysis among groups was presented. Conclusion: EM variables could be
considered as biomarkers to measure the aging effect and functionality of the brain. Video-oculography is
a suitable technique for measuring EM in clinical practice. Significance: The ocular healthy pattern as well
as the methodology followed in this clinical study, is the base for ongoing studies aiming to incorporate EM
analysis at routine practice as markers in early diagnosis for patients with neurodegenerative diseases like
Alzheimer’s dementia or Parkinson’s disease.
INDEX TERMS Aging, biomarker, measurement techniques, statistical analysis, healthy pattern.
I. INTRODUCTION
The ocular movements study is a rich source of information
about brain functionality and useful from the clinical and
scientific points of view.
The complex and elaborated mechanism that generates the
eye movements (EM) involves different regions of the human
brain: Dorsolateral Prefrontal Cortex (DLPFC); Frontal Eye
Field (FEF); Parietal Eye Field (PEF); Visual Cortex (VC);
Superior Colliculus (SC); Brainstem saccade generators;
Basal Ganglia (BG); Cerebellum and Thalamus.
Nowadays, in clinical practice, the EMs are mostly evalu-
ated qualitatively and subjectively and thus only some abnor-
malities in EM can be observed but not quantified or mea-
sured. Sometimes, clinicians use their finger, pencil or a
lighter to generate a visual target to see or follow. Smooth
pursuit, optokinetic reflex, saccadic movement, and vergence
are frequently evaluated in this way.
Saccade paradigm offers the best ratio between useful
information and a time-consuming test. Saccades are defined
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as fast conjugate eye movements that shift the eyes from
one target to another, focusing the object of interest into
the fovea. The fovea is the central area of the retina that
enables the best visual acuity, it has around 2mm of diameter,
causing saccades be accurate. Saccades can be voluntary or
involuntary movements with around 500 ◦/sec and have a
duration of 100 ms [1].
To evaluate EM accuracy, it is necessary the use of spe-
cific technology and procedure. In 1963, David Robinson [2]
published a method for measuring eye movement using a
scleral search coil in a magnetic field. Through two magnetic
fields in quadrature phase and two coils on the lens, hori-
zontal, vertical, and torsional eye movements were measured
simultaneously. The scleral search coil is considered the gold
standard in eye movement measurement. However, since it
is an invasive method, its use is far from being extended to
clinical practice. Furthermore, the test must be performed
and interpreted by qualified personnel, which is also a barrier
towards its generalized implementation.
During the last four decades non-invasive systems were
developed for measuring eye movements. These systems can
be classified into two categories from a technological point
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of view: electro-oculography (EOG) or video-oculography
(VOG). The EOG system measures the electrical signal gen-
erated when the eyes move. Here, some electrodes must be
placed around the eyes in contact with the skin [2]–[6]. The
VOG systems consist of, at least, one camera that records
the eye/s movement. Some authors suggest that the VOG
system is replacing EOG because of its accuracy and simplic-
ity [7]–[9]. Therefore, thanks to technological improvements,
the EM is started to be measured quantitatively in an increas-
ing number of medical centers.
Measurement and characterization of EM may pro-
vide important information in several neurological disor-
ders [10]–[13]. Many research studies about EM have been
reported in prevalent neurodegenerative diseases such as
Alzheimer’s dementia, Parkinson’s disease, frontotemporal
dementia, supranuclear progressive palsy, mind cognitive
impairment, and others [14]–[19]. Besides, the alteration of
EM could even become early markers for the diagnosis of
specific neurological disorders. However, these studies use
different technologies and follow different protocols and pro-
cedures, therefore it is difficult to obtain conclusions of their
measurements.
The first step to EMs being considered in clinical practice
is to develop a standard procedure in order to guarantee the
reproducibility of the measure. Then, using this standard,
clinical trials must be performed to get normal and abnormal
values of the movement in healthy and pathological condi-
tions.
This article aims towards establishing the first systematic,
standard for measuring the EM using a VOG technique. Nor-
mal values of saccadic paradigms (visually-guided saccades,
memory-guided saccades, and antisaccades) in 145 healthy
volunteers (between 18 years old and 86 years old) are pre-
sented.
Data presented in this article are considered as ‘‘healthy
pattern’’ for clinical use in order to compare with pathological
conditions and to develop further studies in neurodegenera-
tive disorders.
All volunteers were informed about the main objective of
the research and signed informed consent. Previous to EM
measure, each subject was interrogated about pathologies
and neurological symptoms, and at least a MoCA, Mini-
Mental, Stroop, or Viena test were performed to exclude some
potential cognitive abnormalities in these subjects. Taking
into consideration the age, volunteers were divided into four
groups. Group A between 18 and 40 years old (nGA = 33),
Group B between 41 and 50 years old (nGB = 14), Group C
between 51 and 60 years old (nGC = 29) and Group D more
than 61 years old (nGA = 69).
This article is organized as follows: Section II describes
the brief background about the relationship between EM and
brain functionality. Section III presents the technology used
for the measurement. Section IV describes the paradigm used
in the clinical trial. Section V describes the results, while the
discussion is made in Section VI. Finally, the main conclu-
sions of this research and the futures step are presented.
This research is authorized by the National Spanish
Agency for Drugs and Medical Devices (AEMPS) and fol-
lows the European protection data law.
II. BACKGROUND ON EYE MOVEMENT AND NEURAL
CONNECTIONS
The generation of an eye movement toward a new stim-
ulus in the visual field involves two problems: to control
the direction and to control the amplitude of the movement
in order to locate the stimulus on the fovea. A saccade
can be defined as a fast (between 400◦/sec and 800◦/sec)
volunteer or reflex eye movement between two fixed
points [20].
The amplitude is controlled by the duration of neuronal
activity in the lower motor neurons of the oculomotor nuclei
and is correlated with the duration of the burst of action
potentials in the abducens neurons [21].
The direction of eye movement is controlled by the local
circuit neurons in two gaze centers in the reticular forma-
tion, each of them is responsible for generating movements
along a particular axis: horizontal and vertical. The horizontal
gaze center is a collection of local circuit neurons near the
midline in the pons responsible for generating horizontal eye
movements. The vertical gaze center is located in the rostral
part of the midbrain reticular formation and is responsible for
vertical movements. Activation of each gaze center separately
results in movements of the eyes along a single axis, either
horizontal or vertical [11].
Besides, two structures that project to the gaze centers
are demonstrably important for the initiation and accurate
targeting of saccadic eye movements: the superior colliculus
of the midbrain, and a region of the frontal lobe that lies just
rostral to the premotor cortex, known as the frontal eye field
(located at Brodmann’s area 8) [11], [22].
Commonly, saccadic movements are directed towards
a stimulus. Besides, there are two variants of this
visually-guided saccades (or prosaccades): memory saccades
(in which the target is the position of a previously shown stim-
ulus) and antisaccades (in which an intentional movement
must be made towards the opposite direction to a suddenly
appearing peripheral visual target) [23].
Some studies in human and nonhuman primates demon-
strated that the dorsolateral prefrontal cortex and particularly,
area 46 of Brodmann and the adjacent Brodmann area 9, both
located in the middle frontal gyrus, are involved in the control
of memory-guided saccades [24]–[27].
In the antisaccade paradigm, an intentional saccade must
be made in the opposite direction to the target, located at one
side of the gaze center (right/left or up/down). To generate
these movements at least two mechanisms are believed to
be required: the inhibition of the unwanted reflexive sac-
cade toward the stimulus (apparently controlled by intrinsic
control of the frontal eye field and the superior colliculus
and externally by the dorsolateral prefrontal cortex and the
substantia nigra pars reticulata); and then the generation of a
volunteer prosaccade in the opposite direction to the target (in
87202 VOLUME 8, 2020
C. E. García Cena et al.: Measurement and Analysis of EM Performance
FIGURE 1. Device for measuring Eye movements.
which lateral intraparietal area and the frontal eye field seems
to be involved).
III. DESCRIPTION OF VIDEO-OCULOGRAPHY SYSTEM
A. HARDWARE DESCRIPTION
OSCANN desk100 is a novel gaze-tracker [13], [28], [29]
designed for clinical practice use. It is based on VOG tech-
nology and the IR-camera captures images at 100 FPS with
a resolution of 1 ms. The measurement is made over the
dominant eye. Before the eye movement test, the operator
must check the dominance of the eyes and move the camera
accordingly.
In order to minimize the head movement, the camera and
infrared light systemwere settled on a mechanism attached to
a chinrest. This mechanism was designed with 3 degrees of
freedom and allows manual adaptation of the system to the
subject’s anatomy.
In Fig. 1, a photograph of the real system is shown. Two
conventional screens with 22’’ and 120 Hz refreshing rate
complete the system. The volunteer is settled in front of the
screen at a distance of 60 cm and the view field is free due
to a hot mirror located in front of his/her eyes that filter
the IR light. The size and the color of the stimulus as well
as the background color of the screen were fixed according
to the medical protocol (Section IV).
The technical characterization of the measurement [20] is
presented in Table 1. The reader should note these values
considered the human factor in the measurement and the
characterization including people of different ages, nation-
alities or visual acuity. Moreover, subjects with contact or
intraocular lenses were included. The values of precision,
resolution, and accuracy make OSCANN desk100 a suitable
system for medical application.
Considering the medical regulatory issues, OSCANN
desk100 is a certified medical device under international
regulation and can be considered as a ‘‘safe device for clinical
practice’’. Table 2 shows the legal requirements follow by the
device.
B. SOFTWARE DESCRIPTION
We developed two software systems that run independently:
OSCANN Capture R© and OSCANN Analyzer R©.
TABLE 1. Technical characterization of the measure.
TABLE 2. Legal aspects certified in OSCANN desk100.
Fig. 2 shows the concepts of software development. The
eye movement is captured through the device (.cls file format
file) and analyzed automatically returning a report (.pdf file
format) to the specialist. The round-trip time is between
3 and 5 minutes and depends on the number of visual tests
performed.
OSCANN Capture software application allows the con-
figuration of the test session, records the video from the IR
camera, and processes it to get gaze localization (positive,
velocity and acceleration) in a file.cls file format. It has
two human-machine interfaces which are described below:
Patient-Machine Interface and Staff-Machine Interface.
The Staff-Machine Interface has many options. A list of
tests can be selected and configured; three different types
of calibration modes are available. Moreover, it is possible
to visualize the graphical results of a test and compared it
with the video recording. This is very useful to evaluate some
unusual eye movements such as nystagmus.
Through Patient-Machine Interface, the stimulus is showed
to the patient. A dot is used as a visual target and its color
changes, from red to green, when the eye movement is
recorded.
A ‘‘demo’’ version is available to assist technicians in this
stage and it is especially useful with patients in cognitive
impairment.
IV. BRIEF DESCRIPTION ON MEDICAL PROTOCOL
One hundred and forty-five healthy volunteers were recruited
according to the following inclusion criteria:
• Age between 18-86 years old. Table 3 summarizes the
main data of each group. The choice of these groups is
not arbitrary and was done in response to the needs of
the ongoing clinical trials (carried out in diseases with
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FIGURE 2. Concept of communication and cloud service.
TABLE 3. Volunteers group classification.
TABLE 4. Default parameters for visual guide saccades test.
different age onset) and the previous literature. We split
the study sample into 4 age groups.
• No personal history of neurological diseases (such as
epilepsy, multiple sclerosis, other neuroimmunological
pathology, neurodegenerative disease, or neurodevelop-
mental disorders) that may alter the EM.
• MoCA (Montreal Cognitive Assessment test) score
higher than 24.
• No personal history of ophthalmological diseases (such
as retinopathy, optic nerve disorders, or others) that
affect visual acuity despite the use of lens correction.
• Visual acuity higher than 0.5 and the absence of uncor-
rected refractive errors.
• Signed informed consent agreement.
A. BATTERY DESCRIPTION
Healthy volunteers carried out the visually-guided saccades
test, memory-guided saccades test, and antisaccades test in
horizontal and vertical axes. The stimulus was a green dot
with a 2 cm diameter and the background color is black.
Fig. 3 describes the horizontal visually guided saccade
test. The stimulus appears in the center of the screen during
1500 ms and the jumps to the right and left (horizontal test)
or up and down (vertical test) randomly. Table 4 presents the
test parameters.
In visually guided saccade test, variables like latency
toward the stimulus, latency back to the center of the screen,
gain (ratio between stimulus and gaze amplitude), accuracy
(hypermetric or hypometria dysmetria), number of blinks,
velocity and anticipated saccades (those performed before
80 ms after the appearance of the stimulus) are measured.
Fig. 4 presents the main variables measured in this visual test.
FIGURE 3. Visually guided saccade test.
FIGURE 4. Main variables computed for visual guided saccade test.
Definition: The Latency is the time (1t) elapsed between
the change of the stimulus (tstimulus) and the first eye move-





. We compute it by (1). In the measure
of latency variable [ms], the anticipated saccades were dis-
carded.
1t (t) = tgaze − tstimulus (1)
Definition: The Gain (2) of the saccade is computed by






Definition: Peak of Velocity [◦/ms] is computed by the
maximum absolute value of the velocity in the saccade move-
ment (3). Here, tini is the time at the first saccadic movement
while tend is the time of the last saccadic movement in the test.
Vp(t) = max (abs (Vt)) t ∈ [tinitend ] (3)
The accuracy of the saccadic movement is an important
value to evaluate brain ageing. The precision of the saccadic
movement must be measured and computed as an error.
In general, this error is called dysmetria and is computed
by (4), where Pistm , Pestm , Pigz and Pegz represent the initial
and final position of the stimulus and the gaze, respectively:
e(t) = sign(Pistm − Pestm ) ∗ (Pigz − Pegz ) (4)
If e(t) > 0 the saccade is hypermetria and if e(t) < 0 it is
hypometria.
In thememory-guided saccade test, volunteers are inquired
to remember the position of the stimulus after it disappears.
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FIGURE 5. Memory guided saccade test.
TABLE 5. Default parameters for memory guide saccades test.
FIGURE 6. Antisaccade test.
Then, he/she must perform a saccadic movement toward
the last position the stimulus appeared. Fig. 5 sketches the
test. The stimulus appears in the center of the screen after
1500 ms a visually guided saccade is done, then the stimulus
comes back to the center and the volunteer must perform
‘‘memory’’ saccade, that means he/she must move his/her
eyes to the last position of the stimulus. Table 5 presents the
main parameters of the test. In the memory-guided saccade
test, the same variables of the visually guided saccade test are
computed. Additionally, the number of correct memory sac-
cades are measured. The accuracy parameter was measured
in the memory saccade.
Fig. 6 describes the antisaccade test paradigm. The volun-
teer must perform amovement in the opposite direction of the
stimulus. Table 6 summarizes the main parameters of the test.
An antisaccade is correct if the volunteer performs a sac-
cade movement in the opposite direction to the stimulus.
When the volunteer performs a movement in the direction
to the stimulus and then corrects the gaze to the opposite
side, this saccade is called ‘‘reflexive’’. In order to measure
the latency of the antisaccade we used (1) and, with (4)
antisaccade dysmetria was computed.
Other variables such as latency, velocity, and duration
of reflexive saccades, antisaccade latency, and its velocity,
TABLE 6. Default parameters for antisaccade test.
FIGURE 7. Main variables computed for Antisaccede Test.
accuracy, and ratio of anticipated, corrected, and successful
antisaccades are measured. The main variables are repre-
sented in Fig. 7.
Definition: The Latency of Reflexive Saccade [ms] (1tref )
is the time elapsed from the time of first gaze’s fixation
(tgazeA) toward the stimulus and the time of the stimulus
change (tstimulus). It is computed by (5).
1tref (t) = tgazeA − tstimulus (5)
Definition: TheDuration of reflexive saccades,∇tref , [ms],
is computed by (6) and it is the difference between the time
at which volunteer fixes the gaze on the stimulus (tiniFIX ) and
the time in which the gaze starts the movement to the opposite
direction (tendFIX ):
∇tref (t) = tendFIX − tiniFIX (6)
V. RESULTS OF CLINICAL STUDY
In this section, the most relevant results are described. Data
are presented together with the linear or quadratic estimation
that best fit to real data. It is made to verify the data tendency
to know when healthy brain ageing is starting. In the follow-
ing figures and equations, the abscissa axis (y) represents the
studied variable while the ordinate axis (x) represents the age
of volunteers.
A. VISUALLY GUIDED SACADDE TEST
Volunteers performed the visually guided saccades in hor-
izontal and vertical with parameters presented in Table 4.
The latency toward the stimulus and the latency coming
back to the center of the screen are computed independently.
Fig. 8 presents the mean values of the horizontal latency
during the test (go to the stimulus and back to the center).
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FIGURE 8. Visually Guided Saccade Test. Horizontal Latency. a) Go to
stimulus, b) Back from stimulus.
FIGURE 9. Visually Guided Saccade Test. Vertical. Latency. (a) Go to
stimulus, (b) Back from the stimulus.
Using a linear estimation model to evaluate the progression
of the values, it is observed that the latency of saccadic
movement is higher with aging in both, horizontal and vertical
movements (7).
yhgo = 187.16+ 0.55x
yh_back = 162.22+ 0.89 (7)
Fig. 9 shows the latencies measured in the vertical tests
while (8) shows the linear estimation of the values (going
toward the stimulus and going back to the center of the
screen).
yv_go = 188.44+ 0.98x
yv_back = 153.59+ 1.25x (8)
Fig. 10 shows the linear estimation and measured values of
visually guided saccades gain. It could be observed that gain
remains constant with aging, then a potential deviation could
reveal a possible neurological impairment
FIGURE 10. Visually Guided Saccade Gain vs Age. Horizontal andVertical.
TABLE 7. Hypermetria in visual guide saccades.
TABLE 8. Hypometria in visual guide saccades.
Comparing (7) with (8), the behavior of latencies in healthy
volunteers seems to be analogous: linear increase and a higher
slope with the age in the returning saccades.
The following Tables, 7 and 8, show the accuracy values
in the saccadic movement. Both, horizontal and vertical axes,
mean accuracy of the age groups is lower in groups with older
volunteers but existing a wide dispersion inside age groups.
B. MEMORY-GUIDED SACADDE TEST
The test was performed following the parameters given
in Table 5. In this case, the latency is computed only in
the memory saccade and the anticipated memory saccades
are discarded from the latency value. Table 9 shows these
measured values.
Figs. 11 and 12 show the latencies of memory guide sac-
cades in horizontal and vertical axes respectively. According
to linear models, (9) and (10), latency increases with the age
in both axes and directions.
yh_go = 176.72+ 2.3x
yh_back = 193.65+ 2.3x (9)
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TABLE 9. Correct and anticipated memory saccades ratio.
FIGURE 11. Memory-Guided Saccade Test. Horizontal Latency. (up) Go to
the stimulus. (down) Back from stimulus.
TABLE 10. Hypermetry in memory-guided saccades.
yv_go = 183.2+ 2.19x
yv_back = 177.02+ 2.19x (10)
Gain values are presented in Fig. 13. As can be easily
observed, in this test, gain values also remain constant along
with the age.
Table 10 and 11 show the accuracy values in memory-
guided saccadic movement in the horizontal and vertical
tests. In this test, median hypometric and hypermetric errors
also increase with age, but again there is a wide dispersion
between subjects in the same group making difficult to find
significant differences. See sub-section D for further discus-
sion.
C. ANTISACCADE TEST
Figs. 14 to 17 show the latency and reflexive latency values
in horizontal and vertical antisaccades tests.
Although the antisaccade latency can be adjusted to a linear
model in the horizontal axis (11) and the vertical axis (13),
the reflexive latency is better approximated by a quadratic
FIGURE 12. Memory Guide Saccade Test. Vertical Latency. (up) Go to the
stimulus. (down) Back from the stimulus.
FIGURE 13. Memory-Guided Saccade Gain Vs Age. (up) Horizontal,
(down) Vertical.
TABLE 11. Hypometry in memory-guided saccades.
polynomial function in both axes (12) and (14).
yh_go = 201.37+ 3.54x
yh_back = 220.01+ 2.08x (11)
yh_RefSaccade = 487.63− 6.43x + 0.12x2
yh_1RefSaccade = 221.96− 5.65x + 0.08x2 (12)
yv_go = 255.26+ 2.54x
yv_back = 241.44+ 1.53x (13)
yv_RefSaccade = 661.67− 13.85x + 0.18x2
yv_1RefSaccade = 374.21− 13.25x+0.16x2 (14)
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FIGURE 14. Antisaccade latency. horizontal test.
FIGURE 15. Latency and duration of horizontal reflexive saccade.
In Table 12, the successful antisaccade ratio is presented
for each age group. It is demonstrated that the inhibitory con-
trol is becoming worse with the age as well as the precision
of antisaccade movement (Table 13 and 14). See sub-section
D for further discussion.
D. STATISTICAL ANALYSIS BY GROUP
Tables 15, 16, and 17 (at the end of the article) show
the values of variables measured in eye movement tests.
Values are expressed in terms of mean±SEM (standard
error of the mean). Differences between groups were
analyzed using one-way ANOVA followed by post-hoc
Tukey’s multiple comparison test for parametric variables,
and the Kruskal-Wallis test followed by Dunn’s test for
non-parametric variables. In all tables, non-parametric vari-
ables are indicated with a letter (a). There are significant
differences among groups if the p-value is less than 0.05 and
non-significative p-values are indicated as ‘‘ns’’.
In the saccadic paradigm presented in this article,
there are no significant differences in eye movement in
FIGURE 16. Antisaccade latency. vertical test.
FIGURE 17. Latency and duration of vertical reflexive saccade.
TABLE 12. Success antisaccade ratio [%].
TABLE 13. Hypermetry in antisaccades test.
Groups A and B. It suggests that brain ageing starts at
40-years-old as it was stated in previous studies with MRI
(magnetic resonance image) [30], [31].
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TABLE 14. Hypometry in antisaccades test.
Groups C and D have significant differences in visually
guided saccades test in blinks number, back latency, and
latency in vertical. In [32] a study withMRI was performed to
140 healthy adults (50-81 years old), it was demonstrated that
change in the volume of the prefrontal cortex is associated
with age.
In memory-guided saccade tests, latency and success rate
of memory saccades present the most significative difference
between groups C and D. In [33] it was demonstrated that
memory task and visual perception was altered: older brains
tend to show more symmetrical activation between hemi-
spheres (either because the activation increases in the less
activated hemisphere or because there is a reduction in the
most activated hemisphere with age).
Many studies relate ageing with the success rate in the
antisaccade test [34], [35]. In this article, we demonstrate that
reflexive saccade latency, as well as its duration, have a non-
linear relation with age and it is a significative variable in
group classification.
If A-B and C-D groups are considered together, there are
significant differences in a large number of parameters in all
eye tests. The latency of saccadic movement is significant.
VI. DISCUSSION
OSCANN desk100 is the first gaze tracker measurement
platform designed for use in clinical practice. To compare
and analyze the pathological eye alterations, it is necessary to
know the normality pattern in the same way as normal values
for sugar or cholesterol in the blood. Due to the novelty of the
hardware and software, it is not possible to compare it with
the existing devices, then clinical trials were necessary.
In order to guarantee the repeatability of the measures they
must be done systematically, then in this work, we established
a standard protocol for studying the saccade paradigm and
we explicitly defined parameters to assess it by OSCANN
desk100.
Most of the gaze trackers available are research-oriented,
allowing the configuration of the experiment and therefore
varying the number of repetitions, the scanned visual field,
or the colour of the stimulus, among others. If any external
parameter is altered, it is not possible to compare the results
since the input or reference signal is not the same, then it
cannot be ensured that measured alteration is due to a specific
brain condition.
Moreover, measuring pure eye movement to get con-
clusions about the functionality of the brain, the head
must remain fixed, since the subject/patient could perform
compensatory cephalic movements and thus alter the mea-
surement.
When measures are made under the same external condi-
tions (patient position, head fixation, form, shape, and colour
of both, background and stimulus, order to be done to volun-
teer/patient, etc.) it is possible to consider it as a standard.
Moreover, we have built a relevant dataset with a relatively
large number of healthy subjects from a wide spectrum of
age and a systematic evaluation of the different paradigms of
saccadic movement.
The main limitation of our study is its transversal design.
This limitation is overcome by the relatively large num-
ber of subjects that we evaluated and using our study and
others [36], [37], we can establish that longitudinal studies
should be targeted in the future for older ages in which
changes are of higher magnitude.
Eye movements are altered in several neuropsychiatric
diseases such as Parkinson’s disease or Alzheimer’s disease.
These movements can be a source of biomarkers that may
improve diagnostic and monitoring performance in clinical
practice for a large number of disorders [38]. The develop-
ment of biomarkers requires the construction and interpre-
tation of database from healthy subjects in each acquisition
system. First, data from healthy subjects is needed to under-
stand the normal evolution of eye movements during ageing.
Apart from the importance of understanding the neurobiology
of aging in eye movements, this is also critical in the design
of trials for search biomarkers. Second, data from adequate
control subjects are important to adequately interpret results
from individual patients with neurological disorders and also
from clinical studies devoted to EM biomarker research.
Previous studies have evaluated saccadic performance in
healthy populations, but few have performed a systematic
evaluation including a large number of parameters in the same
study [39], [40]. Our results are in line with the findings of
these studies but we believe that the evaluation of saccadic
performance as a whole is also a significant contribution of
our work, that is needed to the development of a systematic
approach to assess saccadic performance.
The evaluation of saccadic performance has been pointed
out by several types of studies as a valid approach to ageing
and likely, for neurodegenerative disorders. Saccadic perfor-
mance is sustained by a complex neural network that changes
in adaptation to ageing [41]–[43]. This neurobiological sub-
strate highlights the importance of saccadic performance as
a tool to approach brain function. Moreover, several studies
have demonstrated a correlation between several saccadic
parameters and cognitive function, both in aging and neurode-
generative disorders [43].
Considering the different groups of age that we had estab-
lished a priori, we believe that subjects form group A and
group B shows similar eye movements performance due to
the absence of significant differences between them. This
implies that the saccadic performance remains nearly con-
stant from 18 to 45 years of age. In contrast, the groups
of subjects older than 45 years show significant changes
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TABLE 15. Visually Guided Saccade Test. Comparison among groups.
TABLE 16. Memory Guided Saccade Test. Comparison among groups.
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TABLE 17. Antisaccade Test. Comparison among groups.
with age, overall in parameters from antisaccade tests. This
observation seems to be coherent with previous studies and
taking into account the neurobiology of antisaccade tests,
we believe it may be reflecting a decline in the function-
ality of areas related to executive functions that are found
in normal ageing. The practical consequence of this fact
while evaluating saccadic movements in clinical practice or
research is that controlling by age effect is extremely relevant
for patients older than 45 years, which is the age range in
which disorders affecting eye movements found their highest
incidence.
We have also evaluated parameters from the saccade that
returns the fovea to the original position. Interestingly, this
saccade has differences with the prosaccade that targets to a
new target in visually guided saccades. In the horizontal and
vertical back saccades, latencies tend to be lower but increase
more with aging. We hypothesize this is reflecting that the
subject has previous information about the origin position
and that ageing is influencing the ability of the subject to
control eyemovement according to this information. This fact
is also confirmed in the latency of memory saccade where the
subject knows where he/she must fix the gaze.
Finally, in this paper, we found parameters independent
from the age. Any alteration in these ocular variables would
be due to potential neurological disease and this analysis is
particularly interesting from a clinical or research point of
view.
VII. CONCLUSION
In this article, we presented a systematic procedure to mea-
sure eye movements and data analysis for healthy adults.
In order to consider eye movements a biomarker for normal
ageing and thus assist in the diagnosis of neurodegenerative
diseases, it is necessary to define a standard such as we
presented in this article.
The results delivered show that the performance of the
eye movements decreases with age and values for the main
variables were presented. Most of the parameters show there
are linear variations with the age, except duration and latency
of the reflexive saccades in the antisaccade test.
This systematic procedure is going to be used with patients
with different types of neurodegenerative disorders such as
Alzheimer’s dementia, frontotemporal dementia, Parkinson’s
disease, and parkinsonisms to get an easy-to-use and non-
invasive biomarker to assist in the diagnosis of these diseases.
The next step is to research on eye movement patterns in
different neurodegenerative diseases that improve the actual
process of diagnosis in a faster and more reliable way.
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